Received Dec 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | UNK | UK170AB | OT |
Patient received an expired ACT-HIB vaccine with no reported adverse event; Initial information received on 10-Dec-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 months old male patient who received an expired HIB (PRP/T) vaccine [ACT-HIB] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, polio vaccine INACT, tetanus vaccine toxoid (TDAP IPV) for Immunisation. On 05-Nov-2025, the patient received unknown dose of suspect HIB (PRP/T) vaccine Powder and solvent for solution for injection of standard strength with lot UK170AB and expiry date 31-OCT-2025 via unknown route in unknown administration site for Immunization with no reported adverse event (expired product administered) (Latency same day). Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
TDAP IPV